Skip to Content

New potential key pathway in patients with ALL

At the 2022 ASH Conference in December, a study was presented that focuses on uncovering key pathways in leukemic-stromal cells through Leukemia-Derived Extracellular Vesicles (LEV) in patients with acute lymphoblastic leukemia (ALL). MD and PhD Signe Modvig from Rigshospitalet in Denmark discussed the findings of this study in this MEDtalk.

Signe Modvig

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top